Male Spouses' Experiences in Providing Support and Care for Women With Breast Cancer: A Qualitative Systematic Review and Metasynthesis.

Cancer NursApr 9, 2025 (epub)

Liyun Kong, Huichen Yang, Yi Li et al.

✦ AI-curated · Sources linked

In 30 seconds

This qualitative systematic review and metasynthesis examined male spouses’ experiences of supporting and caring for women who had survived breast cancer. Using the Joanna Briggs Institute qualitative synthesis method, the authors assessed and synthesized findings from 14 studies. Four themes emerged: positive and negative emotional responses; physical, economic, and social consequences; changes in parenting and intimate relationships; and coping strategies. The review concludes that caregiving can involve substantial challenges and that caregiver support should address multiple needs.

Key findings

  • Synthesis of 14 studies identified four themes spanning emotional responses, caregiving consequences, family and relationship changes, and coping.
  • Male spouses described physical, economic, and social consequences associated with caring for women with breast cancer.
  • Caregiving was linked in the qualitative findings to changes in child-rearing and intimate relationships.

Why it matters

Spousal caregiving may affect caregivers’ wellbeing, family roles, and relationships as well as the support they provide. Recognizing this range of experiences can help healthcare services consider caregivers’ needs alongside those of breast cancer survivors and identify areas where tailored support may be useful.

Source

Published in Cancer Nurs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.